𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy for spinal cord astrocytoma

✍ Scribed by Foreman, Nicholas K.; Hay, Thomas C.; Handler, Michael


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
265 KB
Volume
30
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Chemotherapy for spinal cord astrocytoma
✍ Bouffet, Eric; Amat, Didier; Devaux, Yves; Desuzinges, Claude πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 97 KB

Background. The optimal management of spinal cord astrocytomas remains to be defined, as aggressive surgery and radiotherapy are associated with a high risk of morbidity. The value of chemotherapy has not been assessed. Procedure. The patient in the present report harbored an infiltrating spinal co

Prognostic factors in pediatric spinal c
✍ Eric Bouffet; Alain Pierre-Kahn; Jean Claude Marchal; Anne Jouvet; Chantal Kalif πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 2 views

## BACKGROUND. Factors that could optimize the management of pediatric spinal cord astrocytoma remain unclear and controversial. ## METHODS. To determine the factors that influence the prognosis of pediatric patients with spinal cord astrocytomas, a series of 73 consecutive patients at 13 Fren

Intramedullary spinal cord astrocytoma v
✍ Gene Kopelson; Rita M. Linggood πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 334 KB πŸ‘ 2 views

Fourteen patients with intramedullary spinal cord astrocytoma (Grades I, 11) or glioblastoma (Grades 111, IV) were seen at a major referral center over a 19-year period. Although similar surgical and radiotherapeutic techniques were used for each group, the nine patients with astrocytoma had a five-

Chemotherapy for acute lymphoblastic leu
✍ VainionpÀÀ, Leena; Kovala, Tero; Tolonen, Uolevi; Lanning, Marjatta πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 2 views

Intrathecal chemotherapy has been deter-ALL after receiving intrathecal methotrexate mined to cause transient or permanent parapare-therapy during the induction and CNS therapy sis due to myelopathy in patients with leukemia phases when compared with their controls. The or other malignancies. To sys

Therapy for patients with high grade ast
✍ Stefan Madajewicz; Naveed Chowhan; Arafat Tfayli; Clemente Roque; Allen Meek; Ra πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 202 KB πŸ‘ 1 views

## Background: High grade astrocytomas account for approximately 40% of all primary brain tumors. the median survival is approximately 8-10 months for patients with glioblastoma multiforme and 36 months for patients with anaplastic astrocytoma. the results of systemic chemotherapy in the treatment